Roche Holding AG
RHHBY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.88 | -2.31 | -3.55 | -11.66 |
| FCF Yield | 7.47% | 5.88% | 5.76% | 5.00% |
| EV / EBITDA | 13.92 | 11.95 | 12.17 | 15.60 |
| Quality | ||||
| ROIC | 13.22% | 19.21% | 22.23% | 21.39% |
| Gross Margin | 73.90% | 74.19% | 67.53% | 68.63% |
| Cash Conversion Ratio | 2.19 | 1.40 | 1.44 | 1.48 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.76% | -1.27% | 4.11% | -0.50% |
| Free Cash Flow Growth | 31.79% | -14.19% | -16.74% | 39.67% |
| Safety | ||||
| Net Debt / EBITDA | 1.77 | 1.38 | 1.04 | 1.16 |
| Interest Coverage | 9.56 | 15.44 | 28.74 | 41.25 |
| Efficiency | ||||
| Inventory Turnover | 2.14 | 2.01 | 2.19 | 2.55 |
| Cash Conversion Cycle | 160.25 | 177.26 | 168.82 | 145.24 |